Transcription factor NF-kappaB is biochemically coupled to the T cell antig
en receptor (TCR) and activated transiently during an adaptive immune respo
nse. The author's laboratory is investigating the signal dependent regulati
on of NF-kappaB, its downstream gene targets, and its function in lymphocyt
e biology. Our studies have revealed novel enzymatic checkpoints in the NF-
kappaB signaling pathway and constitutive repressors of NF-kappaB that migh
t be clinically applicable for therapeutic control of the immune system. We
have also found that the Tax transforming protein encoded by human T cell
leukemia virus type I (HTLV1)binds to and persistently activates an inducib
le protein kinase in the TCR/NF-kappaB axis. This viral/host interaction ap
pears to trigger the inappropriate expression of NF-kappaH and the developm
ent of HTLV I-associated disease.